International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant... von Novello, S., Torri, V., Grohe, C., Kurz, S., Serke, M., Wehler, T., Meyer, A., Ladage, D., Geissler, M., Colantonio, I., Cauchi, C., Stoelben, E., Ceribelli, A., Kropf-Sanchen, C., Valmadre, G., Borra, G., Schena, M., Morabito, A., Santo, A., Gregorc, V., Chiari, R., Reck, M., Schmid-Bindert, G., Folprecht, G., Griesinger, F., Follador, A., Pedrazzoli, P., Bearz, A., Caffo, O., Dickgreber, N.J., Irtelli, L., Wiest, G., Monica, V., Porcu, L., Manegold, C., Scagliotti, G.V.

Volltext

Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus s... von Novello, S., Torri, V., Grohe, C., Kurz, S., Serke, M., Wehler, T., Meyer, A., Ladage, D., Geissler, M., Colantonio, I., Cauchi, C., Stoelben, E., Ceribelli, A., Kropf-Sanchen, C., Valmadre, G., Borra, G., Schena, M., Morabito, A., Santo, A., Gregorc, V., Chiari, R., Reck, M., Schmid-Bindert, G., Folprecht, G., Griesinger, F., Follador, A., Pedrazzoli, P., Bearz, A., Caffo, O., Dickgreber, N.J., Irtelli, L., Wiest, G., Monica, V., Porcu, L., Manegold, C., Scagliotti, G.V.

Volltext

Analysis of circulating biomarkers in a randomized phase II trial of maintenance oral metronomic vinorelbine in advanced NSCLC following platinum-based chemotherapy: A correlative... von Boeri, M., Nichetti, F., Porcu, L., Torri, V., Del Conte, A., Martinetti, A., Sottotetti, E., Vattemi, E., Verderame, F., Garassino, M.C., Cavanna, L., Tuzi, A., Irtelli, L., de Braud, F.G.M., Platania, M.

Volltext

P1.09 Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation in NSCLC von Brocco, D., Lanuti, P., Simeone, P., Bologna, G., De Tursi, M., Irtelli, L., Di Marino, P., Peri, M., Marchisio, M., Miscia, S., Tinari, N.

Volltext

139PAnalysis of circulating biomarkers in a randomized phase II trial of maintenance oral metronomic vinorelbine in advanced NSCLC following platinum-based chemotherapy: A correlat... von Boeri, M, Nichetti, F, Porcu, L, Torri, V, Del Conte, A, Martinetti, A, Sottotetti, E, Vattemi, E, Verderame, F, Garassino, M C, Cavanna, L, Tuzi, A, Irtelli, L, de Braud, F G M, Platania, M

Volltext

PS01.04 International Tailored Chemotherapy Adjuvant Trial : ITACA Trial. Final Results von Novello, S., Monica, V., Serke, M., Grohe, C., Meyer, A., Geissler, M., Colantonio, I., Stoelben, E., Cecere, F., Schutte, W., Schumann, C., Valmadre, G., Borra, G., Schena, M., Morabito, A., Santo, A., Chiari, R., Gregorc, V., Reck, M., Manegold, C., Griesinger, F., Follador, A., Ferrari, A., Bearz, A., Caffo, O., Dickgreber, N., Irtelli, L., Wiest, G.h., Sotoparra, H., Spatafora, M., Righi, L., Torri, V., Porcu, L., Arizio, F., Scagliotti, G.

Volltext

Clinical efficacy and endocrine activity of vorozole in postmenopausal breast cancer patients. Results of a multicentric phase II study von Boccardo, F., Amoroso, D., Iacobelli, S., Irtelli, L., Farris, A., Mustacchi, G., Mesiti, M., Brema, F., Pacini, P., Cortesi, E., Nardini, P., Guida, G., Langenaeken, C.

Volltext

A phase I study of recombinant interferon-α administered as a seven-day continuous venous infusion at circadian-rhythm modulated rate in patients with cancer von IACOBELLI, S, GARUFI, C, IRTELLI, L, MARTINO, M. T, SANTOBUONO, F, VICARIO, G, TINARI, N, FIORENTINO, B, INNOCENTI, P, NATOLI, C

Volltext

Neo-adjuvant chemo-radiotherapy for operable breast cancer. Preliminary results of an ongoing phase II study von Pacini, P., Ausili-Cefaro, G.P., Nardone, L., Rinaldini, M., Irtelli, L., Menichelli, C., Bagnoli, R., Rubagotti, A., Boccardo, F.

Volltext

PP-5-5 CMF vs Tamoxifen (TAM) Plus Goserelin (GOS) as Adjuvant Treatment of ER Positive (+VE) Pre-Perimenopausal Breast Cancer Patients (PTS). Preliminary Results of an Ongoing Ita... von Boccardo, F., Rubagotti, A., Amoroso, D., Mesiti, M., Geraci, O., Delia, P., Villa, E., Aldrighetti, D., Genta, F., De Sanctis, C., Irtelli, L, Donati, D., Pacini, P., Scotto, T., Schieppati, G.

Volltext

49 Adjuvant high dose chemotherapy (H.D. CT) without bone marrow rescue in breast cancer patients (B.C. Pts) with 10 or more positive axillary nodes (N ≥ 10): Preliminary findings... von Brema, F., Patrone, F., Amoroso, D., Ballestrero, A., De Sanctis, C., Ferrando, F., Folco, U., Irtelli, L., Mammoliti, S., Mesiti, M., Pacini, P., Rinaldini, M., Venturini, M., Boccardo, F.

Volltext

0.31. CMF vs tamoxifen (TAM) plus goserelin (GOS) as adjuvant treatment of ER positive (+VE) preperimenopausal breast cancer patients (pts). Preliminary results of an ongoing Itali... von Boccardo, F., Rubagotti, A., Amoroso, D., Mesiti, M., Geraci, O., Delia, P., Villa, E., Aldrighetti, D., Genta, F., Sismondi, P., Irtelli, L., Donati, D., Paccini, P., Farris, A., Schieppati, G.

Volltext

0-28. Adjuvant high dose chemotherapy (HD CT) without bone marrow rescue in breast cancer patients (b.c. pts) with 10 or more positive nodes ( N ≥ 10): preliminary results of an It... von Amoroso, D., Boccardo, F., Rubagotti, A., Ballestrero, A., Ferrando, F., Brema, F., Genta, F., Sismondi, P., Sertoli, M.R., Rosso, R., Folco, U., Irtelli, L., Iacobelli, S., Mammoliti, S., Mesiti, M., Pacini, P., Rinaldini, M., Patrone, F.

Volltext

Lack of Effectiveness of Adjuvant Alternating Chemotherapy in Node-Positive, Estrogen-Receptor-Negative Premenopausal Breast Cancer Patients: Results of a Multicentric Italian Stud... von Boccardo, Francesco, Rubagotti, Alessandra, Amoroso, Domenico, Perrotta, Alessandra, Sismondi, Piero, Farris, Antonio, Mesiti, Mario, Gallo, Luigi, Pacini, Paolo, Villa, Eugenio, Agostara, Biagio

Volltext

Psychopathology: An International and Interdisciplinary Perspective von Robert Woolfolk, Lesley Allen, Federico Durbano, Floriana Irtelli

Volltext